Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5B5J

Hen egg white lysozyme with boron tracedrug UTX-97

Summary for 5B5J
Entry DOI10.2210/pdb5b5j/pdb
DescriptorLysozyme C, 2-cyano-3-((6-(((2-((2-cyanoethyl)(borocaptate-10B)sulfonio)acetyl)carbamoyl)oxy)hexyl)amino)quinoxaline 1,4-dioxide, SODIUM ION, ... (4 entities in total)
Functional Keywordsboron cluster drug, complex, hydrolase
Biological sourceGallus gallus (Chicken)
Cellular locationSecreted: P00698
Total number of polymer chains1
Total formula weight15591.72
Authors
Morimoto, Y. (deposition date: 2016-05-11, release date: 2017-06-28, Last modification date: 2024-10-16)
Primary citationMorimoto, Y.,Nagasawa, H.,Uto, Y.,Chatake, T.,Hori, H.
Structural Insight Into Protein Binding of Boron Tracedrug UTX-97 Revealed by the Co-Crystal Structure With Lysozyme at 1.26 angstrom Resolution.
J Pharm Sci, 105:2298-2301, 2016
Cited by
PubMed Abstract: Boron neutron capture therapy (BNCT) is one of the numbers of radiotherapies for treatment of certain cancers. The ability of low-dose irradiation with neutrons or radioactive beams to provide an acceptable quality of life is an objective which has not yet been achieved; therefore it will be necessary to increase the efficiency of the neutron capture reaction by lower dose irradiation and by achieving higher drug concentrations in living cells. Drug selectivity in targeting the affected cellular compartment is most important. Molecular design and synthesis of drugs should be based on high resolution structures and analysis of specific compounds and host molecules; however, it is necessary to obtain crystals for X-ray structural analysis. Because compounds containing bulky functional groups are difficult to crystalize due to their flexibility, the method described here makes it possible to stabilize these compounds by complexing them with protein molecules. We have first solved the three-dimensional structure of a BNCT drug-protein molecule combination at 1.26 Å resolution, and discuss the nature of the interaction between a BNCT drug and the protein molecule residues.
PubMed: 27422088
DOI: 10.1016/j.xphs.2016.06.005
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.26 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon